The neutralizing characteristics of monoclonal antibodies directed to four antigenic sites on the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus were determined. Neutralization by each antibody resulted in a persistent fraction of nonneutralized virus which varied from 1 to 17% depending on the hemagglutinin-neuraminidase site recognized, but not on the antibody. In spite of numerous studies (for reviews, see references 6-8, 10, 22, and 28), we remnain without a clear understanding of the mechanisnm(s) of neutralization of animal viruses by virus-specific antibody. Still to be answered is an important aspect of the problem, namely, the number of antibody molecules required to neutralize the infectivity of a single virion. Can neutralization be effected by a single antibody molecule or is it a multihit phenomenon?
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The one-antibody hypothesis is based chiefly on kinetic considerations-inactivation of viral infectivity by antibody proceeds with first-order kinetics (12) , suggesting that a single-antibody molecule can neutralize a virus particle. However, there is considerable evidence from several other approaches suggesting that more than one antibody is required (7) . The recent development of monoclonal antibody technology (19) has provided a new approach which may ultimately lead to a resolution of this question.
Newcastle disease virus (NDV) is the prototype of the paramyxovirus genus of the Paramyxoviridae (17) and was used extensively in the earlier studies on neutralization (11, 26, 27) . Monospecific but polyclonal antibodies to both the hemagglutinin-neuraminidase (HN) and fusion (F) glycoproteins of paramyxoviruses have been shown to possess neutralizing capabilities (23) . We have prepared a panel of monoclonal antibodies specific for the HN glycoprotein of NDV and, in a previous report (16) , have shown by competition antibody-binding radioimmunoassays that these antibodies delineate four antigenic sites on the HN spike. These sites are recognized, respectively, by immunoglobulin G antibodies HN1a, HN1b, and HNlc (site 1), HN2a and HN2b (site 2), HN3a (site 3), and HN4a, HN4b, and HN4C (site 4) . Antibodies to each site also exhibit specific neutralizing capacities characteristic of that site. Furthermore, neutralization by antibodies to the different sites is additive to the * Corresponding author. extent that the additive neutralization profile corresponds exactly to the epitope map determined by competition antibody-binding assays and thus confirms these site assignments (16 MATERIALS AND METHODS Virus. The Australia-Victoria (1932) (AV-WT) strain of NDV was grown in the allantoic sac of 10-day-old embryonated hen eggs at 37°C from a stock of virus that was one egg passage from cloning (3). After the death of the majority of the embryos, allantoic fluid was harvested and filtered through 0.2-,um filters (Acrodisc; Gelman Sciences, Inc., Ann Arbor, Mich.) before storage at -70°C. For some experiments, virus was purified from unfiltered allantoic fluid as described previously (5, 30) .
Cells. Primary and secondary chicken embryo cells were prepared and maintained in standard medium as described previously (3, 14) . Confluent secondary cultures (24 to 48 h after plating) in 60-mm tissue culture dishes were used for plaque titrations.
Chinese hamster ovary (CHO) cells were maintained in spinner culture as previously described (24 screening, and cloning of hybridomas, purification of antibodies from ascites fluids, and initial characterization of monoclonal antibodies have all been described previously (16) . The monoclonal antibody concentration in each ascites preparation was determined by comparing the amount of 125I-labeled second antibody bound in a solid-phase radioimmunoassay (16) to that bound by an affinity-purified preparation (9) of one of the anti-HN monoclonal antibodies (32) . Initially, ascites fluids were heat inactivated at 56°C for 30 min to deplete complement, but since no difference was seen in neutralization assays, this treatment was discontinued.
Polyclonal mouse and rabbit sera. BALB/c mice were immunized as described previously (16) (16) is shown in Fig. 1 . The percentage of virus surviving antibody treatment is plotted against the concentration of antibody in ascites fluid (all adjusted to an initial antibody concentration of 100 pg/ml), rather than simply against the dilution of ascites fluid. This standardization to antibody concentration eliminates the possibility that observed differences in neutralization might be due to differences in antibody concentration. By this criterion, the specific neutralizing activity of antibody HN3a is only slightly greater than that of HN4a, and it is four-to eightfold greater than that of HNlb and HN2a. Results with nine antibodies directed to the four sites on HN suggest that the specific neutralizing activity may be site specific (Table  1) .
However, further examination of Fig. 1 shows that this type of comparison, even when made as a function of antibody concentration, does not provide a true reflection of the neutralizing capabilities of these antibodies: neutraliza- tion obtained with increasing concentrations of each antibody is not proportional to that measured as specific neutralizing activity. Indeed, at high antibody concentrations, HN1b, rather than showing one of the lowest neutralizing activities, actually causes the greatest neutralization; HN4a, which appears to be one of the more potent neutralizers when measured by specific neutralizing activity, is actually the least potent as measured by the persistent fraction of virus surviving antibody treatment.
The greater neutralizing activity of antibody HNlb and the lower efficacy of HN4a are shown very dramatically in Fig. 2 , where the kinetics of neutralization by antibodies to the four sites have been measured at a saturating (see Fig. 4 ) antibody concentration of 50 ,ug/ml. HN4a leaves a persistent fraction of ca. 15%, whereas antibody HN1b leaves a persistent fraction which is a log lower. Persistent fractions for all nine anti-HN monoclonal antibodies measured under conditions of antibody excess are also shown in Table 1 2 . Kinetics of neutralization. Monoclonal antibodies were diluted to 50 ,ug/ml in HBSS and mixed at 25°C with an equal volume of allantoic fluid from AV-WT-infected eggs (5 x 106 to 1 x 107 PFU/ml). Samples (0.1 ml) were removed at the time intervals shown and diluted in 0.9 ml of cold HBSS to stop the reaction. After serial dilution in cold HBSS, 0.2 ml of the appropriate dilutions were plated in duplicate, and the plaque assay was performed as described in the text. The data shown are for antibodies HN1b (-), HN2a (0), HN3a (H), and HN4a (0). Anti-NP again served as the control and was not neutralizing (data not shown).
imposed by the use of a 50% neutralization point as a measure of antibody titer. The only exception to the sitespecific level of neutralization is the slightly lower persistent fraction after treatment with antibody HN4b relative to that achieved with other antibodies to the same site (Table 1) . This might suggest that antibody HN4b is directed to a different epitope within the same site as HN4a and HN4c.
Possible explanations for high persistent fractions in neutralization assays. A number of possible causes for the phenomenon of high persistent fractions in neutralization assays can be envisioned. These involve each of the three components in the neutralization assay system: virus, antibody, and the host cell.
(i) Variation in the virus stocks? Although our virus stocks are only two passages from cloning (3), it is possible that high persistent fractions left after treatment of virus with anti-HN monoclonal antibodies are due to the presence of a high percentage of variants which can escape neutralization. To explore this possibility, virus was picked from those plaques which were formed after treatment individually with an antibody to each of the four sites. These were then grown in embryonated eggs and retested for neutralizability. In every instance, treatment of this virus preparation with the same antibody resulted in neutralization at the same rate and with the same persistent fraction as the original virus (data not shown). Thus, as one might have expected in light of its magnitude, the persistent fraction is not due solely to genetically stable nonneutralizable variants present in our cloned virus stocks. Of course, this experiment does not rule out the existence of phenotypically variant particles in our stocks.
(ii) Aggregation in the virus stock? It is also possible that persistent fractions can be attributed to the presence of aggregates in our virus stocks. The presence of preexisting aggregates in our virus stock was ruled out by the use of allantoic fluid preparations routinely filtered through 0.2-pLm filters before treatment with antibody as described above. Virus capable of passing through these filters showed identical neutralization kinetics and persistent fractions as unfiltered virus (data not shown).
(iii) Virus with higher affinity for host cell receptor than antibody (i.e., neutralizing antibody of low affinity)? We have previously shown that the avidities of these antibodies differ very little (16) . However, this analysis was performed in a binary system measuring the avidity of antibody binding to virus in a solid-phase radioimmunoassay (16). We had not determined the effect of introducing a third variable, the host cell, into the system. If virus had a higher affinity for host cell receptors than for antibody and if the virus-antibody binary complex were constantly dissociating and reassociating, one might expect the persistent fraction of virus surviving treatment with antibody to increase gradually with adsorption time on the host cell monolayer. We therefore compared the kinetics of infection by virus treated with anti-HN and anti-NP (control) antibodies. The results of this experiment are shown in Fig. 3A ; PFU are plotted as a function of increasing adsorption time for virus which has been treated with antibody HN4b or the control antibody. In both cases, nearly maximal infection is found within 10 min of exposure to the host cell. Moreover, the percentage of infectivity remaining after neutralization relative to the nonneutralized control hovers around 20% at all adsorption times tested, especially near 30 min, which is the normal protocol for our experiments (Fig. 3B ). This provides a strong argument against either dissociation or avidity as the sole cause of the persistent fraction. (4) and West Nile (25) (1, 13) . We therefore used further neutralization by RAM as an assay for the presence of bound antibody on the virus in the persistent fraction. Figure 5 shows an example of such an experiment, in which the persistent fraction of virus surviving neutralization by antibody HN4C was diluted and treated with RAM. The addition of RAM gave a further reduction in the persistent fraction, the magnitude of which depended on the concentration of second antibody. Similar treatment of the persistent fractions left by other antibodies with RAM also gave greatly enhanced neutralization, ranging from two to three logs, depending on the antibody (Table 3) , whereas normal rabbit serum did not neutralize (data not shown). As before, the addition of more of the initial antibody also was not neutralizing. Similar results were obtained with complement, except that, unlike RAM, it was able to neutralize virus without prior addition of antibody (data not shown), probably due to the virucidal effect described by Welsh (31 Treatment of the persistent fraction left by any of our antibodies with RAM gives a further two-to three-log reduction in infectivity in every case. Thus, our task is to explain the apparent anomaly that all the viral particles bind monoclonal antibody, yet as many as 1 to 15% of them, depending on the site specificity of the antibody, retain their infectivity and the fact that antibodies to four antigenic sites are required for complete neutralization.
The evidence for a single-hit model for neutralization of enveloped animal viruses is based primarily on kinetic observations (12) . The initial phase of the neutralization curve shows an immediate exponential inactivation of viral infectivity. Although our data also show this (Fig. 2) , our first sample was taken 2 min after the addition of antibody to virus. Whether our findings are really supportive of singlehit kinetics or simply reflect the limitations of our ability to measure the rapid kinetics of the system is unclear. Lafferty (20) has demonstrated a lag in the neutralization of influenza virus with polyvalent serum when the neutralization reaction is run at low temperature.
Evidence for a multiple-antibody mechanism of neutralization has been gathered in several systems with both polyclonal and monoclonal antibodies (reviewed by DellaPorta and Westaway [7] ). Granoff (11, 12) showed that phenotypically mixed particles of two strains of NDV leave high persistent fractions of nonneutralized virus after treatment with antisera to either strain, but neutralization is essentially complete if antisera to both strains are used in tandem. Bradish et al. (2) found with foot-and-mouth-disease virus that the infectivity surviving in equilibrated virusantibody mixtures is due to complexes of virus and antibody. These infectious virus-antibody complexes-"sensitized" virus-were further characterized by the demonstration that the addition of anti-gamma globulin can neutralize them (1, 13) to the point that one can now use this system as an assay for bound antibody. More recently, monoclonal antibodies to Sindbis virus glycoprotein El have been shown to both neutralize and enhance virus infectivity, depending on the antibody concentration (4) . The enhancement of infectivity is mediated by the presence of Fc receptors on the host cell. We feel that enhancement of infectivity does not apply in the NDV-chicken cell system because in fluorescence assays with uninfected cells, antibody added to the cells is not detected either at the surface or inside the cell (data not shown) and because persistent fractions were found on other cell types (Table 2) , including Vero cells, which do not bear Fc receptors (4, 25) .
Although we are aware of the pitfalls inherent in comparing neutralization mechanisms in nonenveloped and enveloped viruses, we feel that our data is consistent with that recently obtained with nonenveloped viruses. Perhaps the most convincing evidence for a multihit model for neutralization comes from studies with a monoclonal antibody to poliovirus which gives first-order neutralization kinetics but which requires an average of four bound antibodies per virion to neutralize the virus (15) . This contrasts with the antibody-induced cooperative transition in the poliovirus capsid proposed by Mandel (21) to explain single-hit kinetics.
In this report, we have presented evidence supporting a multihit model for the neutralization of an enveloped virus, NDV. A site-specific percentage of virus retains its infectivity despite having antibody bound to it. It may be that although all viral particles can indeed bind antibody, only a certain percentage of it is bound bivalently and only then does it cause neutralization. One may even invoke the existence of phenotypic variants in our virus stock having different amounts of the HN glycoprotein. We are presently exploring these theories through the isolation and use of sitespecific variants which escape neutralization and the use of monovalent Fab fragments in neutralization assays.
